Evidence map›Paper›PMID 34390334›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2022

Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease.

Jing Liu, Maria Clarissa Tio, Ashish Verma, Insa M Schmidt, Titilayo O Ilori, Felix Knauf, Finnian R Mc Causland, Sushrut S Waikar

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Jing LiuRenal Division, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China.ORCID 0000-0001-8802-0783
Maria Clarissa TioRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ashish VermaRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9497-6327
Insa M SchmidtSection of Nephrology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0002-0420-6570
Titilayo O IloriSection of Nephrology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Felix KnaufDepartment of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
Finnian R Mc CauslandRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sushrut S WaikarSection of Nephrology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0003-4004-326X
Boston University · USBrigham and Women's Hospital · USCharité - Universitätsmedizin Berlin · DE

Funding

Urinary Biomarkers of Chronic Kidney Disease Pathology and ProgressionU01DK085660 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT, WAIKAR, SUSHRUT S. · 2009 to 2019
$5.3M
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 NephropathyK23DK119542 · NIDDK · BOSTON MEDICAL CENTER · PI ILORI, TITILAYO OMOLARA · 2020 to 2024
$928k
Harvard Chronic Kidney Disease Research Biopsy CenterUH3DK114915 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSAS, SYLVIA E, WAIKAR, SUSHRUT S. · 2019 to 2021
$900k
The Boston University Kidney and Medical Engineering Program (BU-KIDMEP)R25DK128858 · NIDDK · BOSTON MEDICAL CENTER · PI CHITALIA, VIPUL C, WAIKAR, SUSHRUT S. · 2021 to 2025
$637k
Metabolomics and Renal Functional ReserveR21DK119751 · NIDDK · BOSTON MEDICAL CENTER · PI WAIKAR, SUSHRUT S. · 2019 to 2020
$503k
NIDDK NIH HHS K23 DK119542NIDDK NIH HHS K23DK119542NIDDK NIH HHS R21 DK119751NIDDK NIH HHS R25 DK128858NIDDK NIH HHS U01 DK085660NIDDK NIH HHS UH3 DK114915
6 · The paper itself

Abstract

contextAbnormalities in calcium metabolism are common in chronic kidney disease (CKD). Diminished urinary calcium excretion may promote vascular calcification and increased urinary calcium excretion may lead to nephrolithiasis and nephrocalcinosis, conditions associated with CKD.

objectiveTo study predictors of urinary calcium excretion and its association with adverse clinical outcomes in CKD. DESIGN, SETTING AND PATIENTS: This study assessed 3768 nondialysis participants in the Chronic Renal Insufficiency Cohort study from April 2003 to September 2008. Participants were followed up to October 2018. EXPOSURE: Clinically plausible predictors of urinary calcium excretion and 24-h urinary calcium excretion at baseline.

main outcome measuresUrinary calcium excretion; incident end stage kidney disease (ESKD), CKD progression [50% estimated glomerular filtration rate (eGFR) decline or incident ESKD], all-cause mortality, and atherosclerotic cardiovascular disease events.

resultseGFR was positive correlated with 24-h urinary calcium excretion. The variables most strongly associated with 24-h urinary calcium excretion in males and females were 24-h urinary sodium (β = 0.19 and 0.28, respectively), serum parathyroid hormone (β = -0.22 and -0.20, respectively), loop diuretics (β = 0.36 and 0.26, respectively), thiazide diuretics (β = -0.49 and -0.53, respectively), and self-identified black race (β = -0.23 and -0.27, respectively). Lower urinary calcium excretion was associated with greater risks of adverse outcomes, but these associations were greatly attenuated or nullified after adjustment for baseline eGFR.

conclusionUrinary calcium excretion is markedly lower in individuals with CKD compared to the general population. Determinants of urinary calcium excretion differed between sexes and levels of CKD. Associations between urinary calcium excretion and adverse clinical events were substantially confounded by eGFR.

Indexed as

AgedAtherosclerosisCalciumConfounding Factors, EpidemiologicDisease ProgressionFemaleFollow-Up StudiesGlomerular Filtration RateHumansIncidenceKidney Failure, ChronicMaleMiddle AgedProspective StudiesRenal EliminationRenal Insufficiency, ChronicCalciumall-cause mortalitycardiovascular eventschronic kidney diseasedeterminantsrenal outcomesurinary calcium excretion

Identifiers

PMID34390334
PMCPMC8684460
OpenAlexW3191393817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.